EDITORIAL SECTION

Articles

Market Access Strategies for Pharma Products in Europe: A Comprehensive Guide

The European pharmaceutical market is dynamic and diverse presenting both opportunities and challenges for companies seeking market access This guide delves into effective strategies for navigating the complexities of market access in Europe focusing on key aspects such as reimbursement pricing and overcoming market entry challenges

European Pharmaceutical Legal Frameworks: Compliance, Legislation and Regulatory Obligations

If youve ever opened the EUs pharmaceutical rulebook and felt your eyes glaze over youre not alone Directives regulations guidelines delegated acts it can feel like reading a legal maze with no exit sign

Plant-derived Edible Nanoparticles in Delivering Cancer Drugs: Fact or Fad?

Plantderived edible nanoparticles PDENPs are nanosizedvesicles obtained from edible plants such as grapefruit curcumin ginger broccoli and lemon They contain miRNAs bioactive lipids and proteins which play an important role in cell signaling regulation of plant immunity and transport of bioactive molecules into mammalian cells As the world attempts to overcome

Pharmaceutical Serialization in Europe: Ensuring Safety in the Supply Chain

Over the past few years however Europes pharmaceutical companies have faced a rather challenging role of fighting counterfeiting of medicines and therefore their patients Serialization it is a system that uses a special code assigned to every product has become one of the salient solutions to tackle counterfeit drugs While serialization in terms

The Role of European Pharma in Global Healthcare Advancements

Europe is one of the largest players in the international market for health care due to research development and innovation and competitive pharmaceutical industries Some of these European pharma medical research organizations and health care systems have continually provided valuable solutions to the welfare of people globally It is an increasingly important role for them to play given that they...

The Rise of In Vivo Gene Editing: New Opportunities in Therapeutic Innovation

For most of the past decade genetic medicine has been defined by a logistical paradox The science was astonishing the operations were artisanal Cells were drawn from a patient flown to a specialist facility edited tested released and flown back for infusion after conditioning chemotherapy The results in several inherited blood disorders and aggressive cancers were among the most striking modern me...

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys